SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-22-018970
Filing Date
2022-12-23
Accepted
2022-12-23 16:09:07
Documents
4
Period of Report
2023-02-08

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20230208xpre14a.htm PRE 14A 251132
2 GRAPHIC tmb-20230208xpre14a005.jpg GRAPHIC 144089
3 GRAPHIC tmb-20230208xpre14a006.jpg GRAPHIC 170752
4 GRAPHIC tmb-20230208xpre14a001.jpg GRAPHIC 2819
  Complete submission text file 0001558370-22-018970.txt   690317
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-14778 | Film No.: 221485465
SIC: 2834 Pharmaceutical Preparations